Month: August 2015

Doug Fabian has an interesting weekly ETF report. This week’s report can be viewed at www.youtube.com/watch?v=bItZB6x7vZs. On of his key indicators is the 200day moving average line. If an ETF/stock/mutualfund passes below that moving average line, he sells.

James Rohrbach was a guest on one of Gary Kaltbaum shows this week. He produces a couple of reports each week where he says be in the NYSE and/or Nasdaq or be out. His latest signals for the NYSE was a sell on 7/24 and for Nasdaq was a sell on 6/29. He suggest the ProFunds or Rydex funds for intesting in the NYSE – SP500. When you think the market is in an up trend, send an email to Jim@rixindex.com and he will send you his latest news letter.

Returns for the month of July were poor.
In July IRA#1 -5%, IRA#2 +2%, PDP PIE PIZ DWAS +1%, QQQ -2%, SPY/RSP -1%, Power4 +0%.
For the last 3 months, IRA#1 -9%, IRS#2 +3%, PDPetc +1%, QQQ new, SPY/RSP new, Power4 +2%.
May portfolio changes:
IRA#1 – Purchased SBiotechnology on 07/20.
IRA#2 – Purchased SmallCapGrowth on 07/20, sold SBiotechnology on 07/27.
PDP PIE PIX DWAS – Purhased PDP on 7/17, sold PDP on 7/27.
QQQ – Purchased QQQ on 7/17, sold half QQQ on 7/27 – first month for this portfolio.
SPY/RSP – Purchased SPY on 07/17 – first month for this portfolio.
Power4 – Sold PTF on 07/07, purhased PTF on 7/17.

IBD TBP’s Market Pulse is “Market in Correction”
This was probably one of the worst weeks I’ve had. I think that if a federal reserve guy had not come out on Wed and indicated perhaps they would not raise rates in Sep. the market might not have had the big rally it had. Then on Thursday we had the newly improved gross domestic product number – this is at least the second time this administration has change the calculation to make it look better. As the Follow The Money Weekly podcast said on 29Jul15, “We do not have free markets – central planning by governments are controlling the markets.” China’s central planning is failing. Is our’s next?

My current investments:
IRA#1
None
IRA#2
None

My portfolio changes this weekend:
IRA #1 – None
IRA #2 – None

My portfolio market exposure after this weekend’s changes:
IRA #1 – 00% invested
IRA #2 – 00% invested

The Fox Business Block on Saturday reported that this week was the largest decline in the market since October 1987.
In that same business block, Gary B. Smith said he was scared and was buying gold.
Gary Kaultbaum was on Fox Business News Friday evening. He is 100% cash. He indicated his feeling is that this is the start of something big.
The 7 stocks/ETFs I own were all sold this week by the stop loss orders I maintain. I keep a table of the highest close since I purchase the stock/ETF and keep a stop loss order entered at 7% less than that highest close. I previously used 8% but found any investment which down 7% always went to 8% or higher loss.

IBD TBP’s Market Pulse is “Market in Correction” – In Marhew Glagani’s book “How to Make Money in Stock – Getting Started” he says in a market in correction there are 3 rules:
1. Don’t make new buys.
2. Protect yourself (sell to protect gains or stop losses).
3. Prepare now to profit in the next uptrend.

My current investments:
IRA#1
SBiotechnology has a price of 245.69, a sell price 264.79, a rank of 18, and is a Sell. I should have sold it last week and put up with the Fidelity phone calls when I broke their excessively stupid rule to hold funds for 30 days or they can limit in the future your fund purchaeses. My next buy will be presented as a buy this fund, or buy this comperable ETF and maintain a stop loss – no holding periods on ETFs. Most 401ks will not let you do that but any IRA will (as long is you are not in a fund only IRA). Fidelity will lose the fund management fee but charge me $8 to buy and sell. All in all they will lose money. As an example, if you hold 100k in SBiotechnology for 6 months, Fidelity currently earns about $370 and may earn more but currently, voluntaryly limits their total charge $575.
IRA#2
SPharmaceuticals has a price of 23.04, a sell price 23.67, a rank of 05, and is a Sell.
SHealthCare has a price of 225.75 a sell price 234.54, a rank of 16, and is a Sell.
SmallCapGrowth has a price of 19.90, a sell price 20.14, a rank of 07, and is a Sell.

My portfolio changes this weekend:
IRA #1 – SBiotechnology
IRA #2 – SHealthCare, SPharmaceuticals, SmallCapGrowth

My portfolio market exposure after this weekend’s changes:
IRA #1 – 00% invested
IRA #2 – 00% invested

After several down weeks, on Monday Stanley Fischer, The Federal Reserve’s vice chairman, made comments suggesting that perhaps the FED will not raise interest rates next month and the market went up for the week.
Doug Fabian, in his Friday podcast, said we are entering the red zone. The months of August, September, and October are notorious for having sudden market drops. The November through April period, especially during a presidential election year, is the growth season.
Fidelity has that dumb rule about holding a fund for 30 days or they may stop you from buying again and charge a fee. etfdb.com lists 35 ETFs with a objective similar to FBIOX. IBB and FBIOX have 90 day performance within 0.5% and ETFs can be sold any time and even have a stop order to sell if the sell price is hit during the day. It does cost $8 to buy and sell IBB but there is no holding period.
Fidelity has a new phone system which does not work. If you call and identify yourself as a customer with a userid and password, you are put on hold because all agents are busy. I called 7 times on 15Aug and hung up after 5 to 32 minutes on hold. If you want to talk to someone, do not identify yourself as a current customer and then they pick up immediately. 

IBD TBP’s Market Pulse is “Uptrend Under Pressure” – Not a Time to invest.

My current investments:
IRA#1
SBiotechnology has a price of 262.09, a sell price 264.79, a rank of 07, and is a Hold. It is only a hold because of the Fidelity short term trading rules for funds. When I finally got through to Fidelity (as a potential customer) to get the exact date, the guy did not know and his systems were down. The way I calculate it I will sell it next weekend unless it goes up at least $2.71.
IRA#2
SPharmaceuticals has a price of 24.39, a sell price 23.67, a rank of 04, and is a Hold.
SHealthCare has a price of 239.20 a sell price 234.54, a rank of 11, and is a Hold.
SmallCapGrowth has a price of 20.80, a sell price 20.14, a rank of 06, and is a Hold.

My portfolio changes this weekend:
IRA #1 – None.
IRA #2 – None.

My portfolio market exposure after this weekend’s changes:
IRA #1 – 100% invested.
IRA #2 – 60% invested.

Chris Mayer was on the 328th Frank Curzio’s podscast (15Jul15) where he talked about his research into the basis of his new book. In 2014 he studied eash stock which went up 100X since 1962 and found 365 stocks. The underlying principles he is now using to identify stocks which will go up 100X in the future. His book 100-Baggers has now been published. In the podcast he indicates his current best pick in HLTH. It may be worth watching.

The Follow The Money Weekly podcast on 29Jul15 made the following observations:
1. We do not have free markets – central planning by governments are controlling the markets. 18 different countries are buying up securities to keep their markets going including China which has purchased 147B to buy securities and keep its market up.
2. The US fed will soon have to start QE4.  
3. Since we will soon be giving Iran 150B dollars, look out as they spend more on their objectives to kill all the citizens of the US and Israel. The administration has stated some of this will be spent to support terrisam
4. The Chinese market has had the biggest drop since 2007 – remember what happened after 2007.
5. Since the deal with Iran is coming, Saudi Arabia is having Russia build 16 nuclear reactors so they can get the bomb before Iran can.
6. US House members who voted to prevent states from labeling GMO foods received an average of 109k contributions from big agriculture firms.
7. 3 US supreme court members voted for favorable results for the companies in which they held stock 90% of the time without recusing themselves.
 He goes on to say that we have the best government money can buy.

Interesting view of Buble 2.0 http://www.zerohedge.com/news/2015-08-05/housing-2006-redux-mortgage-fraud-and-speculation-come-roaring-back

Not sure SBiotechnology owned AQXP but it was up 482.12% on Friday. I wish I had owned it.
 
IBD TBP’s Market Pulse is “Uptrend Under Pressure” – Not a Time to invest.

My current investments:
IRA#1
SBiotechnology has a price of 265.56, a sell price 264.79, a rank of 04, and is a Hold.
IRA#2
SPharmaceuticals has a price of 24.39, a sell price 23.67, a rank of 02, and is a Hold.
SHealthCare has a price of 239.20 a sell price 234.54, a rank of 09, and is a Hold.
SmallCapGrowth has a price of 20.80, a sell price 20.14, a rank of 07, and is a Hold.

My portfolio changes this weekend:
IRA #1 – None.
IRA #2 – None.

My portfolio market exposure after this weekend’s changes:
IRA #1 – 100% invested
IRA #2 – 60% invested

So I spend a lot to time explaining the etfdb.com free tools tab and ended up deleting my text. That explaination will have to wait until the next fund buy date. Take a look at that free tool and see how many ETFs can match the same objective as your favorate fund. ETFs can be sold at any time, have lower management fees, and are not subject to stupid rules like Fidelity’s hold for 30 day hold rule.

IBD TBP’s Market Pulse is “Uptrend Under Pressure” – Not a Time to invest.

My current investments:
IRA#1
SBiotechnology has a price of 278.73, a sell price 264.79, a rank of 01, and is a Hold.
IRA#2
SPharmaceuticals has a price of 24.92, a sell price 23.67, a rank of 02, and is a Hold.
SHealthCare has a price of 245.85 a sell price 234.54, a rank of 05, and is a Hold.
SmallCapGrowth has a price of 21.20, a sell price 20.14, a rank of 06, and is a Hold.

My portfolio changes this weekend:
IRA #1 – None.
IRA #2 – None.

My portfolio market exposure after this weekend’s changes:
IRA #1 – 100% invested
IRA #2 – 60% invested